Marker Therapeutics, Inc. (MRKR)
Nasdaq · Pharmaceutical Preparations · Inc. DE
What they're doing
Not enough recent activity to summarise.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing director or officer change
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2024-12-23 | NEA Partners 16, L.P. | ten percent owner | P | 554,250 | 3.2 | $1,773,600 |
| 2024-12-23 | ELMS STEVE | director | P | 11,085 | 3.2 | $35,472 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.
Recent filings
- 2026-08-14 10-Q
- 2026-05-15 10-Q
- 2026-05-04 8-K
- 2026-03-20 DEFA14A
- 2026-03-20 ARS
- 2026-03-20 DEF 14A
- 2026-03-19 8-K
- 2026-03-18 10-K
- 2026-03-10 PRE 14A
- 2026-02-09 8-K
- 2025-11-19 4
- 2025-11-19 4
- 2025-11-19 4
- 2025-11-17 SCHEDULE 13D/A
- 2025-11-14 SCHEDULE 13G/A
- 2025-11-14 8-K
- 2025-11-13 10-Q
- 2025-11-05 8-K
- 2025-11-04 4
- 2025-11-04 4